Trial Condition(s):
Magnetic Resonance Imaging, Liver neoplasms
Study to evaluate the diagnostic efficacy of contrast-enhanced MRI with a single intravenous injection of Gd-EOB-DTPA versus contrast-enhanced spiral CT in patients with known or suspected focal malignant liver lesions
Bayer Identifier:
90444
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations |
|---|
Trial Design
A multicenter intra-individual comparative study to evaluate the diagnostic efficacy of contrast-enhanced MRI with a single intravenous injection of Gd-EOB-DTPA (SH L 569 B) at a dose of 25 μmol/kg BW versus contrast-enhanced spiral CT in patients with known or suspected focal malignant liver lesions
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
